Intrauterine growth restriction in a low-income country: Risk factors, adverse perinatal outcomes and correlation

Bolajoko O Olusanya1

  • 1Department of Community Health and Primary Care, University of Lagos, Idiaraba, Surulere, Nigeria. boolusanya@aol.com

Insights

Intrauterine growth restriction-low birth weight (IUGR-LBW) is linked to poor nutrition and adverse outcomes in newborns. Early detection and improved prenatal care for teenage mothers are crucial in resource-limited settings.

Area of Science:

  • Neonatal Health
  • Perinatal Epidemiology
  • Global Child Health

Background:

  • Intrauterine growth restriction-low birth weight (IUGR-LBW) poses significant risks to newborns.
  • Effective monitoring and management are challenging in resource-poor settings lacking routine growth surveillance.
  • Understanding risk factors and outcomes is vital for targeted interventions.

Purpose of the Study:

  • To identify risk factors for IUGR-LBW.
  • To assess adverse perinatal outcomes and nutritional status in the first week of life for IUGR-LBW infants.
  • To evaluate these factors in settings without routine intrauterine growth monitoring.

Main Methods:

  • Cross-sectional study in an inner-city Nigerian hospital.
  • Defined IUGR-LBW as term infants (<2500g).
  • Assessed nutritional status using WHO-MGR z-scores (HAZ, HCZ, WAZ, WHZ) and analyzed risk factors/outcomes via multivariable logistic regression.

Main Results:

  • 145 (4.3%) infants had IUGR-LBW.
  • Associated with teenage mothers (OR:2.90), lack of antenatal care (OR:1.88), and female gender (OR:1.38).
  • IUGR-LBW infants showed poor nutritional status (p<0.001) and increased risk of sepsis (p=0.053), hyperbilirubinemia (p<0.001), and special care admission (p=0.009).

Conclusions:

  • IUGR-LBW correlates with poor early-life nutritional status based on WHO-MGR.
  • Early detection of affected infants is feasible for surveillance in resource-poor settings.
  • Improved prenatal care, especially for teenage mothers, is essential to reduce the IUGR-LBW burden.
Abstract

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience, such as differences...
Regression Toward the Mean01:52

Regression Toward the Mean

Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when researchers try to extrapolate results...